Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc
Followers
7K
Following
5K
Media
2K
Statuses
7K
Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425
Boston, MA
Joined February 2022
RT @antgiorda: Positive results announced from the PIK3CAwild-type cohort of Phase 3 VIKTORIA-1 trial evaluating @celcuity gedatolisib + fu….
0
3
0
Check out this recent study examining patterns of presentation, treatment, and survival among older adults with #MetastaticBreastCancer. @stolaney1 @nlinmd @DrRFreedman #OlderAdultsWithBreastCancer #MBC
0
4
12
The Breast Oncology Center is leading the #ETHANstudy, a randomized study for men with stage I-III hormone receptor-positive (HR+)/HER2-negative #BreastCancer. This research study is looking to see how well #MaleBreastCancer responds to pre-surgery treatment with endocrine
0
4
10
RT @ValenzaCarmine: Happy to be part of this incredible family!.❤️❤️.@DFCI_BreastOnc @DanaFarber .@AnnPartridgeMD @GuiNaderMarta @DrKateDib….
0
3
0
RT @CCortiMD: Pleased to share the results of our prospective observational decision-impact study in early-stage HR+/HER2− breast cancer (N….
0
8
0
RT @PTarantinoMD: Results from VIKTORIA-1 just announced by @celcuity. The addition of gedatolisib to 2L fulvestrant/palbo improved PFS fro….
0
22
0
RT @stolaney1: So nice to see this-- wonderful for our patients that our breast cancer therapies keep expanding!!!. @DFCI_BreastOnc.
0
5
0
Check out the #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (July 18th-25th, 2025). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch
0
7
22
Check out this paper on omission of multimodal therapy in older adults with high-risk #BreastCancer. 👉@eliza_lorentzen @annabellejones2 @OKantorMD.@EMittendorfMD @TariKingMD
0
12
28
Follow-up results from the POSITIVE Trial regarding breastfeeding after hormone receptor-positive #BreastCancer show no differences in breast cancer related events in women who breastfed compared with those who did not. 👉@fedrophd @AnnPartridgeMD
0
28
64
RT @Xanda_Barreto: Wrapping up my observership at @DFCI_BreastOnc with deep gratitude. Thank you to the incredible Palliative Care team fo….
0
1
0
RT @drsarahsam: Tangible goal to implement for everyone including cancer patients. 5000 steps a day looks quite good for all cause mortal….
0
7
0
RT @shilpaonc: Thanks @DrKatyMoore @PTarantinoMD for organizing such a state of the art session on everything about ADCs across solid tumor….
0
8
0
RT @ladolcevitamag_: Merit Award Asco 2025 premia oncologa Abruzzese Caterina Sposetti . #MeritAwardASCO2025 #Oncol….
ladolcevita.tv
Oncologa Caterina Sposetti tra le eccellenze mondiali Tra i migliori ricercatori italiani nel campo dell’oncologia la giovane dottoressa Caterina Sposetti. Si tratta del prestigioso Merit Award Asco...
0
1
0
RT @OncNursingNews: 🧩 Paolo Tarantino, MD, PhD, compares ADCs to Legos because of the moldability of the drug class—watch the full intervie….
0
2
0
RT @cure_today: Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastat….
curetoday.com
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know.
0
4
0
RT @ecancer: DESTINY-Breast09: Trastuzumab deruxtecan + pertuzumab can delay cancer growth in patients with HER2-positive locally advanced….
ecancer.org
Dr Tolaney talks to ecancer at ASCO 2025 about data she presented from the phase 3 DESTINY-Breast09 clinical trial. This found that the combination of trastu
0
8
0
RT @CCO_Education: In this certified on-demand webcast with Sarah Sammons MD, Nadia Harbeck, MD, PhD and Ian Krop, MD, PhD leading experts….
0
2
0
RT @DanaFarber: .@FilipaLynce, MD, FASCO, recently received the Advanced Clinical Research Award in Breast Cancer Research from @ConquerCan….
0
8
0
RT @Icro_Meattini: Is stereotactic #radiosurgery the standard of care for #breastcancer patients with multiple brain met?. Honoured to cont….
0
11
0